Deutsch English Français

Contact

EP0720477

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0720477

EP0720477 - METHOD AND COMPOSITIONS FOR MAINTAINING GLOMERULAR FILTRATION RATE WHILE INHIBITION EXTRACELLULAR MATRIX ACCUMULATION [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 03.10.2003 Database last updated on 03.10.2024
Most recent event Tooltip	03.10.2003	Application deemed to be withdrawn	published on 19.11.2003 [2003/47]
Applicant(s)	For all designated states VANDERBILT UNIVERSITY Nashville, TN 37232-0146 / US
	[N/P]
Former [1996/28]	For all designated states VANDERBILT UNIVERSITY Nashville, TN 37232-0146 / US
Inventor(s)	01 / KON, Valentina 6536 Radcliff Drive Nashville, TN 37221 / US
	02 / FOGO, Agnes 492 Page Drive Mount Juliet, TN 37122 / US
	03 / ICHIKAWA, Iekuni 4378 Chickering Lane Nashville, TN 37215 / US
	[1996/28]
Representative(s)	Perry, Robert Edward Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
	[N/P]
Former [1996/28]	Perry, Robert Edward GILL JENNINGS & EVERY Broadgate House 7 Eldon Street London EC2M 7LH / GB
Application number, filing date	93922168.5	09.09.1993
	[1996/28]
	WO1993US08527
Priority number, date	US19920942756	09.09.1992 Original published format: US 942756
	[1996/28]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9405289
	Date:	17.03.1994
	Language:	EN
	[1994/07]
	Type:	A1 Application with search report
	No.:	EP0720477
	Date:	10.07.1996
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 17.03.1994 takes the place of the publication of the European patent application.
	[1996/28]
Search report(s)	International search report - published on:	US	17.03.1994
	(Supplementary) European search report - dispatched on:	EP	04.03.1996
Classification	IPC:	A61K31/44, A61K31/435	[1996/28]
	CPC:	A61K31/44 (EP,US); A61K31/00 (EP,US); A61K31/4178 (EP,US); A61K31/437 (EP,US); A61K31/4439 (EP,US); A61P13/02 (EP); (+) A61P15/00 (EP); A61P43/00 (EP) (-)
Designated contracting states	AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1996/28]
Title	German:	VERFAHREN UND PRÄPARATE ZUR AUFRECHTERHALTUNG DER GLOMERULÄREN FILTRATIONSRATE BEI GLEICHZEITIGER HEMMUNG DER EXTRAZELLULÄREN MATRIXAKKUMULATION	[1996/28]
	English:	METHOD AND COMPOSITIONS FOR MAINTAINING GLOMERULAR FILTRATION RATE WHILE INHIBITION EXTRACELLULAR MATRIX ACCUMULATION	[1996/28]
	French:	PROCEDE ET COMPOSITIONS PERMETTANT DE MAINTENIR LE TAUX DE FILTRATION GLOMERULAIRE TOUT EN INHIBANT L'ACCUMULATION DE MATRICES EXTRACELLULAIRES	[1996/28]
Entry into regional phase	07.04.1995	National basic fee paid
	07.04.1995	Search fee paid
	07.04.1995	Designation fee(s) paid
	07.04.1995	Examination fee paid
Examination procedure	06.04.1994	Request for preliminary examination filed International Preliminary Examining Authority: US
	10.04.1995	Examination requested [1996/28]
	01.10.1998	Despatch of a communication from the examining division (Time limit: M06)
	12.05.1999	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2003/47]
	15.07.1999	Reply to a communication from the examining division
	29.12.1999	Despatch of a communication from the examining division (Time limit: M06)
	29.06.2000	Reply to a communication from the examining division
	15.09.2000	Despatch of a communication from the examining division (Time limit: M02)
	22.09.2000	Reply to a communication from the examining division
	10.07.2001	Despatch of a communication from the examining division (Time limit: M06)
	18.01.2002	Reply to a communication from the examining division
	18.02.2003	Date of oral proceedings
	18.06.2003	Despatch of communication that the application is refused, reason: substantive examination {1}
	18.06.2003	Minutes of oral proceedings despatched
	01.07.2003	Application deemed to be withdrawn, date of legal effect [2003/47]
Request for further processing for:	15.07.1999	Request for further processing filed
	12.07.1999	Full payment received (date of receipt of payment) Request granted
	27.07.1999	Decision despatched
Fees paid	Renewal fee
	29.03.1996	Renewal fee patent year 03
	24.09.1996	Renewal fee patent year 04
	30.09.1997	Renewal fee patent year 05
	04.09.1998	Renewal fee patent year 06
	03.09.1999	Renewal fee patent year 07
	13.09.2000	Renewal fee patent year 08
	03.09.2001	Renewal fee patent year 09
	05.09.2002	Renewal fee patent year 10
	04.09.2003	Renewal fee patent year 11
	Penalty fee
	Additional fee for renewal fee
	30.09.1995	03 M06 Fee paid on 29.03.1996
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[XY]WO9210182 (SMITHKLINE BEECHAM PLC [GB]) [XY] 1-10 * the whole document * * claims 1,9 *;
		[Y]US5049565 (CHEN SHIEH-SHUNG T [US], et al) [Y] 1-10 * the whole document *;
		[Y]US5087702 (CHEN SHIEH-SHUNG T [US], et al) [Y] 1-10 * the whole document *;
		[XY] - S.D. KIVLIGHN ET AL, "L-158,809: Antihypertensive efficacy and effects on renal function in the conscious spontaneously hypertensive rat (SHR)", FASEB J, vol. 5, no. 6, page a1576 [XY] 1-10 * abstract *
		[PXY] - V. KON ET AL., "Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition", KIDNEY INT, vol. 44, no. 3, doi:doi:10.1038/ki.1993.279, pages 545 - 550, XP000560904 [PXY] 1-10 * the whole document * DOI: http://dx.doi.org/10.1038/ki.1993.279
		[XY] - S.D. KIVLIGHN ET AL., "Antihypertensive efficacy and effects on renal function of L-158,809: A nonpeptide orally active angiotensin II antagonist", HYPERTENSION, vol. 19, no. 1, page I135 [XY] 1-10 * abstract *
		[XY] - Y. KAKINUMA ET AL., "Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure", KIDNEY INT., vol. 42, no. 1, pages 46 - 50 [XY] 1-10 * the whole document *
		[XY] - BOVEE KC ET AL, "Effects of the nonpeptide angiotensin II receptor antagonist DuP 753 on blood pressure and renal functions in spontaneously hypertensive PH dogs.", AM J HYPERTENS, APR 1991, 4 (4 PT 2) P327S-333S, UNITED STATES [X] 1-5,7-10 * the whole document * [Y] 1-10
		[XY] - CHAN DP ET AL, "Renal-specific actions of angiotensin II receptor antagonism in the anesthetized dog.", AM J HYPERTENS, JUN 1992, 5 (6 PT 1) P354-60, UNITED STATES [X] 1-5,7-10 * the whole document * [Y] 1-10
		[PX] - E.P. PETEN, "High dose ACE inhibitor (ACEI) or ANGII receptor antagonist (ANGII RI) therapy does not improve glomerulosclerosis (GS) in mice transgenic for growth hormone (GH mice)", J AM SOC NEPHROL, vol. 4, no. 3, page 780, XP000561045 [PX] 9,10 * abstract *
		[T] - J. HARLOS ET AL., "Antihypertensiva und Proteinurie", NIEREN-HOCHDRUCKKR., vol. 22, no. 11, pages 573 - 582, XP000560993 [T] 1-10 * the whole document * * page 575 *
	International search	[X] - THE FASEB JOURNAL, Vol. 5, issued January 1991, CHANG et al., "In vitro Pharmacology of a Highly Potent and Selective... Antagonist", page A1575, Abstract No. 6993.

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p